Advances in the care of RSV 

 

RSV is a virus that causes significant breathing problems in young children, causing some children to be hospitalized. Since 1998 there has been a medication called Synagis available to babies with significant health problems to help them fight off RSV and protect them from serious problems from RSV. It has been cost prohibitive to provide to children other than those with other serious health problems. 

 

Last year a new drug, Nirsevimab, was approved for use for all babies from birth to age 8 months. This new drug works the same way Synagis does, but it is cheaper and lasts longer;  only one dose a season is required. This drug works by giving your child the antibodies to fight off RSV when your child should come in contact with RSV. This decreases the likelihood of serious problems. 

 

This is recommended for all children that are ages birth - 8 months and:

• Did not receive a dose previously

• Mothers did not receive a dose of the RSV vaccine while pregnant 

• Infant was born less than 14 days after mother received the RSV vaccine

 

We are able to provide this important protection for your child. 

 

If you would like your child to receive this, please call to schedule, (231) 638-4120. We can begin to offer this on Oct 1, 2024.